Results 71 to 80 of about 20,642 (217)

HIV seropositivity among adult tuberculosis patients in Delhi

, 2000
We report HIV seropositivity among tuberculosis patients from our hospital between 1994-99. Of the 500 patients with various forms of tuberculosis, two were found to be seropositive (0.4%).
Sharma, S. K., Siddaramaiah, N. H., Saha, P. K., Pande, J. N., Dixit, Y., Seth, P.   +5 more
core   +1 more source

Stigma, HIV Risk Behavior, and HIV Seropositivity among Hijra and Transgender in India: Insights from Integrated Biological and Behavioral Surveillance

Indian Journal of Public Health
Background: The hijra and transgender (H/TG) persons have enhanced risk of HIV infection. Objectives: We aimed to explore whether there were any associations between stigma, HIV risk behaviors, and HIV seropositivity among H/TG persons in India ...
Nishakar Thakur, Shreya Jha, Sanjay K. Rai, Shashi Kant, Mani Kalaivani, Kiran Goswami, Puneet Misra, Partha Haldar, Yujwal Raj, Srinivas Venkatesh   +9 more
doaj   +1 more source

Efficacy of dolutegravir/lamivudine in adults with HIV‐1 and isolated reactive hepatitis B core antibody: Insights from Phase 3/3b study results

HIV Medicine, Volume 27, Issue 7, Page 1189-1195, July 2026.
Abstract Objectives As two‐drug HIV‐1 antiretroviral therapy (ART) regimens become standard, data gaps remain concerning their safety and efficacy among people with isolated reactive hepatitis B core antibodies (anti‐HBc). Here, we assessed the safety and efficacy of dolutegravir/lamivudine (DTG/3TC) versus three‐ or four‐drug regimens (3DRs/4DRs ...
D. Fox, J. Slim, E. T. Overton, A. Doblado‐Maldonado, P. Jeffery, R. A. Grove, S. D. Advani, R. Borsi, C. M. Parry, M. Underwood, B. Jones   +10 more
wiley   +1 more source

Prevalence of Hepatitis C Virus Infection among People Living with HIV/AIDS Attending Specialist Hospital Sokoto, Nigeria

UMYU Journal of Microbiology Research
The Hepatitis C virus (HCV) remains a large healthcare burden. Human Immunodeficiency Virus (HIV) and HCV coinfection are major global health concerns worldwide.
Iduh, M. U., Enitan, S. S., Umar, A. I., Abbas, A.   +3 more
doaj   +1 more source

Predictors of liver‐related death among people who inject drugs in Vancouver, Canada: a 15‐year prospective cohort study

Journal of the International AIDS Society, 2014
Introduction While HIV/AIDS remains an important cause of death among people who inject drugs (PWID), the potential mortality burden attributable to hepatitis C virus (HCV) infection among this population is of increasing concern. Therefore, we sought to
Kanna Hayashi, Michael‐John Milloy, Evan Wood, Huiru Dong, Julio SG Montaner, Thomas Kerr   +5 more
doaj   +1 more source

Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

Arthritis &Rheumatology, Volume 78, Issue 6, Page 1294-1305, June 2026.
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean, Carrie Richardson, Anthony J. Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

HIV seropositivity in high risk individuals and in pulmonary tuberculosis

, 2017
Background: The association between tuberculosis and HIV has been well known. South Asia especially India is witnessing largest number of new AIDS cases and the epidemic is well established. TB shortens the life expectancy of HIV positive people. Keeping
Gupta, Abhishek, Ahlawat, Amit, Virmani, S.K., Tyagi, Vinod, Tyagi, Puru   +4 more
core   +2 more sources

Demographic and Behavioural Factors in Tanzanian and Norwegian Patients with Sexually Transmitted Infections. [PDF]

, 2006
To evaluate whether differences in demographic or behavioural factors might explain differences in reported or diagnosed sexually transmitted infections (STI), we have compared data from 1097 Tanzanian and Norwegian STI patients.
Langeland, Nina, Chalamila, G., Nilsen, A., Matre, R., Matre, Roald, Nilsen, Arvid, Mwakagile, Davis, Langeland, N., Chalamila, Guerino, Mwakagile, D., Haarr, Lars, Haarr, L.   +11 more
core   +1 more source

Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.

PLoS ONE, 2017
ObjectivesThe study aimed to describe the seroprevalence of hepatitis A virus (HAV) in HIV-positive adult patients in Taiwan between 2012 and 2016 and to examine the evolution of HAV seroprevalence between 2004-2007 and 2012-2016.MethodsClinical ...
Yu-Lin Lee, Kuan-Yin Lin, Chien-Yu Cheng, Chia-Wen Li, Chia-Jui Yang, Mao-Song Tsai, Hung-Jen Tang, Te-Yu Lin, Ning-Chi Wang, Yi-Chien Lee, Shih-Ping Lin, Yu-Shan Huang, Hsin-Yun Sun, Jun-Yu Zhang, Wen-Chien Ko, Shu-Hsing Cheng, Yuan-Ti Lee, Chun-Eng Liu, Chien-Ching Hung, Taiwan HIV Study Group   +19 more
doaj   +1 more source

Safety, Pharmacokinetics, and Dose Recommendations for Nirmatrelvir/Ritonavir in Individuals with Mild to Moderate COVID‐19 and Severe Renal Impairment

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1604-1613, June 2026.
Patients with severe renal impairment and COVID‐19 are at high risk for severe disease and death. Nirmatrelvir/ritonavir, an antiviral therapy for COVID‐19, is eliminated by renal excretion and can accumulate in patients with severe renal impairment.
Jacqueline Gerhart, Candace R. Bramson, Michelle Goulding, Haihong Shi, Olayide Oladoyinbo, Phylinda L. S. Chan, Sunring Chime, Jennifer Hammond   +7 more
wiley   +1 more source